Search Results 1871-1880 of 19665 for hemoglobin
In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...
Hemoglobin ≥ 8 g/dL and independent of transfusion within 7 days of screening. Platelets ≥ 100 x109/L, or ≥ 50 x109/L if bone marrow involvement, and ...
- Hemoglobin ≥ 9 g/dL (within ≤ 28 days prior to registration). * No transfusions ≤ 14 days before cycle 1 day 1 (C1D1). - Total bilirubin ≤ 1.5 x ULN ...
Hemoglobin ≥ 9.0 g/dL (within 30 days prior to registration);; Note: The use of transfusion is acceptable; Creatinine clearance (CrCl) > 30 mL/min (within 30 ...
* hemoglobin ≥ 9g/dL (without use of erythropoietin; without packed RBC transfusion within preceding 2 weeks) * platelet count ≥100,000/?cL * total ...
Hemoglobin ≥ 90 g/L (9.0 g/dL). Patients may be transfused to meet this criterion. AST, ALT, and ALP ≤ 2.5 x upper limit of normal (ULN); Serum bilirubin ...
Hemoglobin < 10 g/dL (100 g/L);. Platelet count < 100 × 109 /L (< 100,000/mm3 );. Absolute neutrophil count (ANC) < 1.5 × 109 /L (< 1500/mm3 );. Absolute ...
Adequate organ and marrow function as defined below: Hemoglobin ≥9.0 g/dL without transfusion 4 weeks prior to the screening and randomization: Absolute ...
Current persistent anemia, defined as hemoglobin \<10g/dL 27. Use of anticoagulation therapy (e.g., warfarin, coumadin, or novel oral anticoagulants \[NOACs ...
Hemoglobin ≥8.0 g/dL (Grade ≤2) maintained for ≥2 weeks from any prior transfusion. Note: In Part 2 (Cohort Expansion), Grade ≥3 neutropenia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!